Microsomal Ca2+-ATPase inhibitors such as thapsigargin (THG), cyclopiazonic acid (CPA) and 2,5-di-(tert-butyl)- 
Introduction
Cystic fibrosis (CF),' the most common lethal inherited disease among Caucasians, is caused by mutations in the gene encoding for the CF transmembrane conductance regulator (CFTR) C1-channel and characterized by defective salt and water secretion by epithelia, which normally can be activated by a cAMPdependent pathway (for reviews see references 1 and 2). The aberrant Cl-secretion, accompanied by increased Na+ absorption, alters the volume and composition of the epithelial surface liquid and leads to complex pathophysiological manifestations, including electrolyte and fluid imbalance, abnormal mucous secretion, bacterial infection, and chronic inflammation (for re-, views see references 1 and 3). Pharmacological strategies aimed at conquering the CF defect in Cl-secretion have in recent years focused on discovering new agents that would stimulate epithelial Cl -secretion through an alternate cAMP-independent mechanism (for review see reference 4) . A number of purinoceptor agonists have recently been shown to enhance Cl-secretion in CF epithelial cells (5) (6) (7) (8) . P2 purinoceptor agonists ATP and UTP, in particular, have been tested in clinical trails (9) .
Purinoceptor agonists apparently activate the plasma membrane Cl -channels in CF epithelia primarily via a preserved Ca2+-dependent signaling pathway (5, 7, 8) involving G proteins and phospholipase C (7) . These agents induce a transient rise in intracellular free Ca2+ ([Ca2 ]')in both normal and CFderived epithelial cells (5, 7, 8) . Activation of membrane Clchannels by such Ca2+-mobilizing agonists, however, tends to be limited by a seemingly concomitantly evoked inhibitory mechanism, which may be. mediated by other intracellular messengers such as diacylglycerol (DAG) (10) and inositol tetrakisphosphate (InsP4) (11 (8) . Briefly, cells were plated on 9 X 22-mm rectangular glass coverslips (Wheaton, Milville, NJ) and studied at 90-100% confluency -1 wk after seeding. Cells were incubated in efflux solution containing 5-10 ,uM fura-2-AM and 0.05% (wt/vol) pluronic F127 for 20-30 min at 37°C and rinsed with dye-free efflux solution. The cell monolayer/coverslip was then mounted vertically in an acrylic cuvette containing 2 ml efflux solution and studied in a spectrofluorimeter (SLM-AMINCO, Urbana (21) . Micropipettes were made as described by Hamill et al. (22) and had a tip resistance of 2-3 MQ. Whole-cell currents were recorded with an Axopatch amplifier (Axon Instruments, Foster City, CA). The resting membrane potential (Vm) was held at -70 mV. To examine the current-voltage (I-V) relation of recorded Cl -currents, Vm was sequentially altered from -100 to 100 mV in 50 mV steps (8, 19, 23) . Voltage-clamp protocols were run with an aid of a Tecmar 12-bit A/D-D/A converter and an IBM-AT computer. Signals, filtered at 1 kHz, were displayed on a strip-chart recorder and stored on floppy disks. Data were analyzed by means of pClamp, version 5.5 (Axon Instruments). Sample sizes are presented as n = number of cells studied.
CaM kinase activity assay. CaMKII Activity assay was carried out essentially as described elsewhere (24, thiothreitol, and 10 jtg/ml leupeptin; pH 7.5) at -1 ml/106 cells. Cells were then disrupted by sonication for 15 s at 4°C, using a sonic cell dismembrator (Fisher Scientific, Pittsburgh, PA). Assay buffers contained 50 mM Pipes, 10 mM magnesium acetate, 10 p.g/ml calmodulin, 10 MM autocamtide-2 (AC-2, a selective substrate of CaMKII) (26), 50 pLM [y-32P]ATP (1 Ci/mmol), and either 1 mM CaCl2 (for Ca2+-stimulated maximal activity) or 2 mM EGTA (for Ca2+-independent or autonomous activity). CaMKII activity in cell homogenates was assayed in triplicate by phosphorylation of AC-2; reactions were carried out for 30 s at 30°C. Background signal was determined in background control assays performed in an AC-2-omitted assay buffer containing EGTA but no Ca2+. The Ca2+-independent or autonomous activity of CaMKII is presented as the percentage of phosphorylation of AC-2 in the absence of Ca2+ with respect to its phosphorylation in the presence of Ca2+ (26, 27) .
Trypan blue exclusion and cell proliferation assay. For the trypan blue exclusion assay, CFPAC-1 cells were grown on 16 x 8-mm rectangular tissue culture chambers (Nunc, Naperville, IL) and studied at 95-100% confluency. The cell culture medium was aspirated, replaced with fresh culture medium or culture medium plus desired agent, and incubated for 6 h in the cell culture incubator. Subsequently, the cell monolayers were rinsed with phosphate buffer solution (PBS) and incubated with 0.4% trypan blue (GIBCO BRL) for 5 min at room temperature. The cell monolayers were rinsed again with PBS and examined by light microscopy. Cells failed to exclude trypan blue and stained in dark blue resulting from trypan blue "invasion" are considered to be of compromised viability.
For the cell proliferation assay, CFPAC-1 cells were cultured on the 36-mm wells of the tissue culture-treated 6-well clusters (Costar, Cambridge, MA) and studied at -30% confluency. The cell culture medium was freshly replaced. 2 h later, the cell cultures were, in groups of six wells each, exposed to 0 (control), 25 Fig. 2 B) , suggesting that DBHQ is also effective in inducing Ca2' release from intracellular stores in CEPAC-1. By comparing the time-course of [Ca 21 ] obtained in the absence and presence of external Ca 21 (1.2 mM, the efflux solution) respectively (see Fig. 2 (30) . The effect of DBHQ on [Ca2 Ii ummarized in Table I .
Activation of membrane ClU channels by DBHQ. Fig. 3 A shows a time-course of the whole-cell ClP currents recorded before and after application of DBHQ (25 MM). DBHQ elicited an outwardly-rectifying depolarization-activated whole-cell current characteristic of Ca 21 -stimulated membrane Cl -current (Fig. 3, B and C) . The recorded currents should be predominantly due to fluxes of Cl-ions because Na + and K + were omitted in the bath and pipette solutions and Cs' used to substitute for pipette K', is known to block K' channels. The reversal potential was near 0 mV (Fig. 3 C) Fig. 3, D and F) .
CaMKII has been suggested to mediate Ca 21 -stimulated Cl -secretion in secretory epithelia (8, 23, 31) Fig. 4 , DBHQ stimulation resulted in an increase in the autonomous activity of CaMKII (P < 0.05). well, respectively (n = 6 wells for each group). The cells from all the three groups grew from the original -30% confluency to 60-70% confluency during the 36-h experimental period. There was no statistically significant difference in cell counts between the DBHQ-pretreated groups and the control group. Also, the DBHQ-pretreated cells remained able to grow to confluency. Thus, DBHQ did not seem to appreciably affect the cell proliferation.
Discussion
Chloride secretion by CF epithelia is defectively regulated by cAMP but remains inducible by a parallel Ca2+-dependent signaling pathway (for reviews see references 1 and 2). We have shown that Cl -conductance in CF-derived epithelial cells fails to respond to cAMP stimulation but can be activated by the Ca2+ ionophore ionomycin (23) . Purinoceptor agonists such as ATP, UTP, and adenosine, which elevate intracellular Ca2", substantially affect cell proliferation. As the experimental faciliCa2 -ATPase inhibitors thus are likely to be therapeutically ties and expertise required for conducting in vivo experimentauseful for improving epithelial C1-secretion in CF. tion are so far unavailable in the authors' laboratory, whether DBHQ would exert any adverse effect in vivo has not yet been Acknowledgments tested. Likewise, the long-term side-effect of DBHQ, if any, remains unknown and needs to be carefully examined. It is Foundation. P. Gardner is a recipient of the Burroughs Wellcome Faculty Scholar Award in Clinical Pharmacology.
